Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-26-035617

Chief Financial Officer gave up 10 shares (to pay taxes)

  • Chief Financial Officer acquired 41 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Foster Jonathan P. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-04 Exercise or conversion : show line 1 in the form +41 20,301 D
2026-11-04 Shares withheld for taxes : show line 2 in the form −10 $8.46 $85 20,291 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-04 Exercise or conversion : show line 3 in the form Restricted Stock Units −41 70,854 D
Loading xslF345X06/rdgdoc.xml…